Clinical pharmacology studies with acenocoumarol. 1979

J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller

In two different studies, the relation between plasma concentrations of acenocoumarol and apparent prothrombin levels (Quick test) was investigated, using a new specific analytical method for the assay of the drug. The prothrombin level appeared independent of the plasma concentration of the drug, which is higher in old patients (over 70 years) than in younger patients (under 51 years).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074 Acenocoumarol A coumarin that is used as an anticoagulant. Its actions and uses are similar to those of WARFARIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p233) Acenocoumarin,Nicoumalone,Mini-Sintrom,Sinkumar,Sinthrome,Sintrom,Syncoumar,Syncumar,Synthrom,Mini Sintrom,MiniSintrom
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging

Related Publications

J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
December 1977, Indian journal of experimental biology,
J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
January 1985, Progress in clinical and biological research,
J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
January 1988, European journal of anaesthesiology. Supplement,
J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
February 1971, British journal of pharmacology,
J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
October 1980, British journal of clinical pharmacology,
J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
February 2011, Wiener medizinische Wochenschrift (1946),
J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
July 1972, The British journal of clinical practice,
J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
September 1988, Orvosi hetilap,
J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
October 1967, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
J Hirtz, and Y Le Roux, and A Jaouen, and J Richard, and C Blatrix, and J J Thébault, and J P Schoeller
March 1952, Pan American medical woman's journal,
Copied contents to your clipboard!